Company Overview and News
World Wrestling Entertainment (NYSE:WWE) shares were up on Friday as the company’s stock was upgraded by a major analyst thanks to optimism regarding its future movement.
MS.PRI MS.PRK WWE MS.PRE MS.PRF MS.PRG MS MS.PRA
While former WWE Women’s champion Stephanie McMahon may now spend more of her time in the C-Suite promoting the media company’s brand, that doesn’t mean she’s given up her athletic streak.
In early February Yahoo Finance posted an article titled “3 reasons the WWE is doomed.” This article will cover the flip-side of that equation; specifically why some hedge-funds are bullish on World Wrestling Entertainment Inc. over the long-term and see large upside in the share price.
Launched on 04/19/2011, the First Trust Small Cap Growth AlphaDEX Fund (FYC - Free Report) is a passively managed exchange traded fund designed to provide a broad exposure to the Small Cap Growth segment of the US equity market.
FYC IWO WWE FMI SAM AAXN
Cigna Corporation: “OK, when [CEO] David Cordani came on, the stock was right around here. I continue to believe it deserves to be much higher. They’re doing an acquisition with Express Scripts. The stock is undervalued."
NEE.PRI NEE.PRJ LRCX WST NEE.PRC WWE NEE.PRQ NEE.PRR CI NEE
Man, do I wish I was a bigger fan of World Wrestling Entertainment (NYSE:WWE). Of course, that’s no guarantee that I would have caught any of the 265% rally in WWE stock over the past year, but it certainly would have helped.
FB V WWE
Former WWE Women’s champion Stephanie McMahon was born into a family engrossed in the world of wrestling — and she couldn’t imagine doing anything else.
Arnel Pineda looked extremely happy as he met another famous and proud Filipino like him recently — Dave “Batista” Bautista.
Below is a list of the 35 best performing stocks in the Russell 3,000 so far in 2018 (through the close on 7/2). Amazingly, one stock has achieved Peter Lynch’s “10-bagger” status in the first six months of the year! As shown, Turtle Beach (HEAR) — a gaming sound card and headset manufacturer — ranks at the top of the list with a 2018 gain of 1,046.8%.
NIHD WWE HEAR
WWE's television rights fee agreements with NBCUniversal and Fox could be a sign of future tailwinds in years to come as the value for sports rights continues to climb higher.
Welcome to the latest episode of the Full-Court Finance podcast from Zacks Investment Research. On this episode, Associate Stock Strategist Ben Rains breaks down World Wrestling Entertainment’s (WWE - Free Report) new TV deals with Comcast’s (CMCSA - Free Report) USA Network and Fox (FOXA - Free Report) . He also takes a look at WWE’s impressive growth, before he heads into some of the latest streaming sports news surrounding the NFL.
WFC WFCNP WFC.WS FB CMCSA WFC.PRL NFLX WFC.PRJ WFC.PRT WFC.PRR WFC.PRQ WFC.PRP WFC.PRO WFC.PRN WWE TWTR WFC.PRY WFC.PRX WFC.PRW WFC.PRV
38m - Asif
History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...
2h - Asif
Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...
22h - Asif
General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...
Silicon Investor Message Boards
This table lists all message boards related to WWE / World Wrestling Entertainment, Inc. on message board site Silicon Investor.
|WWE - A Good Investment?||WWES...Shannon Briggsu0027 heavyweight punch...:o)|
as of ET